Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide in Polycystic Livers
NCT00565097Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2007
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of lanreotide in Polycystic liver disease (PLD), sponsored by Radboud University Medical Center. Started Oct 2007; status: completed.
02
Drugs
lanreotide
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on NCT00565097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565097.